• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchHemogenyx Pharmaceuticals
    Picture of Hemogenyx Pharmaceuticals logo

    HEMO — Hemogenyx Pharmaceuticals Share News

    780.00p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    • Market Cap
      £53.04m
    • Enterprise Value
      £53.41m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • HEMO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    HEMO Dividends
    • Hemo: CAR-T Analytical Release Tests Completed

      23/03/2023 13:32
    • Admission of Shares to Official List

      07/02/2023 14:30
    • Second Price Monitoring Extn

      26/01/2023 09:05
    • Price Monitoring Extension

      26/01/2023 09:00
    • Brief: Hemogenyx Pharma Announces Placing To Raise £4.1 Mln

      26/01/2023 08:40
    • Placing to Raise £4,056,250

      26/01/2023 07:00
    • Brief: Hemogenyx Pharmaceuticals Announces Completion Of Third Process Qualification Run For Manufacture Of Hemo-Car-T Cells

      23/01/2023 07:43
    • Hemo: CAR-T 3rd Process Qualification Run Completed

      23/01/2023 07:00
    • Second Price Monitoring Extn

      16/01/2023 16:40
    • Price Monitoring Extension

      16/01/2023 16:35
    • Second Price Monitoring Extn

      13/01/2023 11:05
    • Price Monitoring Extension

      13/01/2023 11:00
    • Second Price Monitoring Extn

      12/01/2023 16:40
    • Price Monitoring Extension

      12/01/2023 16:35
    • Second Price Monitoring Extn

      12/01/2023 14:05
    • Price Monitoring Extension

      12/01/2023 14:00
    • Price Monitoring Extension

      10/01/2023 16:35
    • Second Price Monitoring Extn

      09/01/2023 09:05
    • Price Monitoring Extension

      09/01/2023 09:00
    • Single CBR Can Treat Multiple Viruses

      09/01/2023 07:00
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.